- Browse by Author
Browsing by Author "Kolbinger, Fiona R."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Artificial Intelligence in Pancreatic Intraductal Papillary Mucinous Neoplasm Imaging: A Systematic Review(medRxiv, 2025-01-09) Qadir, Muhammad Ibtsaam; Baril, Jackson A.; Yip-Schneider, Michele T.; Schonlau, Duane; Tran, Thi Thanh Thoa; Schmidt, C. Max; Kolbinger, Fiona R.; Surgery, School of MedicineBackground: Based on the Fukuoka and Kyoto international consensus guidelines, the current clinical management of intraductal papillary mucinous neoplasm (IPMN) largely depends on imaging features. While these criteria are highly sensitive in detecting high-risk IPMN, they lack specificity, resulting in surgical overtreatment. Artificial Intelligence (AI)-based medical image analysis has the potential to augment the clinical management of IPMNs by improving diagnostic accuracy. Methods: Based on a systematic review of the academic literature on AI in IPMN imaging, 1041 publications were identified of which 25 published studies were included in the analysis. The studies were stratified based on prediction target, underlying data type and imaging modality, patient cohort size, and stage of clinical translation and were subsequently analyzed to identify trends and gaps in the field. Results: Research on AI in IPMN imaging has been increasing in recent years. The majority of studies utilized CT imaging to train computational models. Most studies presented computational models developed on single-center datasets (n=11,44%) and included less than 250 patients (n=18,72%). Methodologically, convolutional neural network (CNN)-based algorithms were most commonly used. Thematically, most studies reported models augmenting differential diagnosis (n=9,36%) or risk stratification (n=10,40%) rather than IPMN detection (n=5,20%) or IPMN segmentation (n=2,8%). Conclusion: This systematic review provides a comprehensive overview of the research landscape of AI in IPMN imaging. Computational models have potential to enhance the accurate and precise stratification of patients with IPMN. Multicenter collaboration and datasets comprising various modalities are necessary to fully utilize this potential, alongside concerted efforts towards clinical translation.Item From marginal gains to clinical utility: machine learning-based percutaneous coronary intervention risk prediction models(Oxford University Press, 2025-01-16) Qadir, Muhammad Ibtsaam; Hira, Ravi S.; Kolbinger, Fiona R.; Biostatistics and Health Data Science, Richard M. Fairbanks School of Public HealthItem Reporting guidelines in medical artificial intelligence: a systematic review and meta-analysis(Springer Nature, 2024-04-11) Kolbinger, Fiona R.; Veldhuizen, Gregory P.; Zhu, Jiefu; Truhn, Daniel; Kather, Jakob Nikolas; Biostatistics and Health Data Science, Richard M. Fairbanks School of Public HealthBackground: The field of Artificial Intelligence (AI) holds transformative potential in medicine. However, the lack of universal reporting guidelines poses challenges in ensuring the validity and reproducibility of published research studies in this field. Methods: Based on a systematic review of academic publications and reporting standards demanded by both international consortia and regulatory stakeholders as well as leading journals in the fields of medicine and medical informatics, 26 reporting guidelines published between 2009 and 2023 were included in this analysis. Guidelines were stratified by breadth (general or specific to medical fields), underlying consensus quality, and target research phase (preclinical, translational, clinical) and subsequently analyzed regarding the overlap and variations in guideline items. Results: AI reporting guidelines for medical research vary with respect to the quality of the underlying consensus process, breadth, and target research phase. Some guideline items such as reporting of study design and model performance recur across guidelines, whereas other items are specific to particular fields and research stages. Conclusions: Our analysis highlights the importance of reporting guidelines in clinical AI research and underscores the need for common standards that address the identified variations and gaps in current guidelines. Overall, this comprehensive overview could help researchers and public stakeholders reinforce quality standards for increased reliability, reproducibility, clinical validity, and public trust in AI research in healthcare. This could facilitate the safe, effective, and ethical translation of AI methods into clinical applications that will ultimately improve patient outcomes.